{"name":"Carruthers Dermatology Centre","slug":"carruthers-dermatology-centre","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Botox Cosmetic™","genericName":"Botox Cosmetic™","slug":"botox-cosmetic","indication":"Temporary improvement of moderate to severe glabellar lines (frown lines between the brows)","status":"marketed"}]}],"pipeline":[{"name":"Botox Cosmetic™","genericName":"Botox Cosmetic™","slug":"botox-cosmetic","phase":"marketed","mechanism":"Botox Cosmetic blocks acetylcholine release at the neuromuscular junction, paralyzing facial muscles and reducing the appearance of wrinkles.","indications":["Temporary improvement of moderate to severe glabellar lines (frown lines between the brows)","Temporary improvement of forehead lines","Temporary improvement of crow's feet (lateral canthal lines)"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}